OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

ATM: Functions of ATM Kinase and Its Relevance to Hereditary Tumors
Sayaka Ueno, Tamotsu Sudo, Akira Hirasawa
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 1, pp. 523-523
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Unveiling the mechanisms and challenges of cancer drug resistance
Sameer Ullah Khan, Kaneez Fatima, Shariqa Aisha, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 85

Crosstalk Between Autophagy and Oxidative Stress in Hematological Malignancies: Mechanisms, Implications, and Therapeutic Potential
Antonio José Cabrera-Serrano, José Manuel Sánchez‐Maldonado, Carmen González‐Olmedo, et al.
Antioxidants (2025) Vol. 14, Iss. 3, pp. 264-264
Open Access | Times Cited: 1

BMAL1 collaborates with CLOCK to directly promote DNA double-strand break repair and tumor chemoresistance
Canfeng Zhang, Liping Chen, Lu Sun, et al.
Oncogene (2023) Vol. 42, Iss. 13, pp. 967-979
Open Access | Times Cited: 16

Germline CHEK2 and ATM Variants in Myeloid and Other Hematopoietic Malignancies
Ryan J. Stubbins, Sophia C. Korotev, Lucy A. Godley
Current Hematologic Malignancy Reports (2022) Vol. 17, Iss. 4, pp. 94-104
Closed Access | Times Cited: 24

Novel Clinical Trials and Approaches in the Management of Glioblastoma
Allison R. Valerius, Lauren M. Webb, Uğur Sener
Current Oncology Reports (2024) Vol. 26, Iss. 5, pp. 439-465
Closed Access | Times Cited: 5

Quinoline and quinolone carboxamides: A review of anticancer activity with detailed structure–activity relationship analysis
Neethu Mariam Thomas, Majed Alharbi, Venkanna Muripiti, et al.
Molecular Diversity (2025)
Closed Access

The Development of ATM Inhibitors in Cancer Therapy
Elizabeth A. Ampolini, Judit Jiménez-Sáinz, David T. Long
Targeted Oncology (2025)
Open Access

Importance of Germline and Somatic Alterations in Human MRE11, RAD50, and NBN Genes Coding for MRN Complex
Barbora Otahalova, Z Volková, Jana Soukupová, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5612-5612
Open Access | Times Cited: 12

Baicalein Induces G2/M Cell Cycle Arrest Associated with ROS Generation and CHK2 Activation in Highly Invasive Human Ovarian Cancer Cells
Tzu‐Chao Chuang, Wei‐Syun Shao, Shih‐Chung Hsu, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1039-1039
Open Access | Times Cited: 11

Germline Variants and Characteristic Features of Hereditary Hematological Malignancy Syndrome
Hironori Arai, Hirotaka Matsui, SungGi Chi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 1, pp. 652-652
Open Access | Times Cited: 4

Review of Novel Surgical, Radiation, and Systemic Therapies and Clinical Trials in Glioblastoma
Allison R. Valerius, Lauren M. Webb, Anna Thomsen, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10570-10570
Open Access | Times Cited: 4

Targeting shelterin proteins for cancer therapy
Wioletta Brankiewicz, Anoop Kallingal, Radosław Krzemieniecki, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 8, pp. 104056-104056
Closed Access | Times Cited: 3

Amentoflavone induces caspase‐dependent/−independent apoptosis and dysregulates cyclin‐dependent kinase‐mediated cell cycle in colorectal cancer in vitro and in vivo
Cheng‐Hsun Lin, Kuang‐Hsuan Lin, Hsiang‐Ju Ku, et al.
Environmental Toxicology (2023) Vol. 38, Iss. 5, pp. 1078-1089
Closed Access | Times Cited: 7

Multicellular Complex Tumor Spheroid Response to DNA Repair Inhibitors in Combination with DNA-damaging Drugs
Thomas S. Dexheimer, Nathan P. Coussens, Thomas Silvers, et al.
Cancer Research Communications (2023) Vol. 3, Iss. 8, pp. 1648-1661
Open Access | Times Cited: 7

CELL CYCLE DYSREGULATION IN CANCER
Antonino Glaviano, Samarendra Kumar Singh, E. Hui Clarissa Lee, et al.
Pharmacological Reviews (2024) Vol. 77, Iss. 2, pp. 100030-100030
Closed Access | Times Cited: 2

Understanding the mechanistic pathways and clinical aspects associated with protein and gene based biomarkers in breast cancer
Tapan Behl, Ankush Kumar, Vishakha Vishakha, et al.
International Journal of Biological Macromolecules (2023) Vol. 253, pp. 126595-126595
Closed Access | Times Cited: 6

Discovery of Thieno[3,2-d]pyrimidine derivatives as potent and selective inhibitors of ataxia telangiectasia mutated and Rad3 related (ATR) kinase
Yunxin Duan, Haodong Cheng, Lili Zhuang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 255, pp. 115370-115370
Closed Access | Times Cited: 5

DON induced DNA damage triggers absence of p53-mediated G2 arrest and apoptosis in IPEC-1 cells
Silu Hou, Jingjiao Ma, Yuqiang Cheng, et al.
Toxicology (2023) Vol. 501, pp. 153707-153707
Closed Access | Times Cited: 4

Targeted sequencing of DNA/RNA combined with radiomics predicts lymph node metastasis of papillary thyroid carcinoma
Runjiao Zhang, Linfei Hu, Yanan Cheng, et al.
Cancer Imaging (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1

Association of variations in the CAT and prognosis in lung cancer patients with platinum-based chemotherapy
Jia-Si Liu, Junyan Liu, Qi Xiao, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 3

Transplantation of Neural Stem Cells-Overexpressed Ku70 Improves Neurological Deficits in a Mice Model of Cerebral Ischemia Stroke
Hui Liu, Chonghua Jiang, Jun Peng, et al.
Neurochemical Research (2023) Vol. 49, Iss. 3, pp. 718-731
Closed Access | Times Cited: 2

Molecular Marvels: Small Molecules Paving the Way for Enhanced Gene Therapy
Sebastian Hasselbeck, Xinlai Cheng
Pharmaceuticals (2023) Vol. 17, Iss. 1, pp. 41-41
Open Access | Times Cited: 2

Page 1 - Next Page

Scroll to top